MG
TFFP

Michael Gelband’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Michael Gelband’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,020
Closed -$685K – 2914
2021
Q1 		$685K Buy
2,020
+67
+3% +$27.2K 0.01% 1145
2020
Q4 		$699K Buy
+1,953
New +$752K 0.01% 1049

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
ACA
Apis Capital Advisors New York $1.03B AUM 383.18% 1-Year Est. Return

Michael Gelband's TFFP Position: Q2 2021 in Review

Michael Gelband sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2021, closing a stake of 2,020 shares — an estimated $685K sold.

Michael Gelband first reported a position in TFFP in Q4 2020 and held it in 2 quarters. The position peaked at $699K in Q4 2020. 59 funds tracked by Wall St. Rank hold TFFP as of Q2 2021.

  • Michael Gelband reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Michael Gelband sold 2,020 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $685K.
  • Michael Gelband first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Michael Gelband's TFF Pharmaceuticals, Inc. Common Stock position peaked at $699K in Q4 2020.
  • 59 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.